(MedPage Today) — The FDA approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent vomiting induced by motion in adults, Vanda Pharmaceuticals announced Tuesday.
The approval marks the first new drug treatment…
Source:
Read full article at www.medpagetoday.com
Medical Disclaimer:
This content is for informational and educational purposes only.
It does not replace professional medical advice.
(MedPage Today) -- On New Year's Eve, Lee Zeldin did something out of character for an Environmental Protection Agency (EPA)...
(MedPage Today) -- Oral semaglutide (Rybelsus) protected against heart failure events in type 2 diabetes patients with a history of...
(MedPage Today) -- Health Secretary Robert F. Kennedy Jr. on Monday announced that his department will devote $100 million toward...
(MedPage Today) -- Patients with advanced non-small cell lung cancer who received immunochemotherapy in the morning or early afternoon had...
(MedPage Today) -- NEW ORLEANS -- More extensive N1 lymph node assessment may better guide therapy after non-small cell lung...
(MedPage Today) -- A young girl was at home doing a handstand when her mother noticed something unusual -- a...
